EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2014. Scientific Opinion on the substantiation of a health claim related to Padina pavonica-extract in Dictyolone® and an increase in bone mineral density pursuant to Article 13(5) of Regulation (EC) No 1924/2006.

EFSA Publication; Inge Tetens

doi:10.2903/j.efsa.2014.3518

EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2014. Scientific Opinion on the substantiation of a health claim related to Padina pavonica-extract in Dictyolone® and an increase in bone mineral density pursuant to Article 13(5) of Regulation (EC) No 1924/2006.

EFSA Publication, Inge Tetens

Abstract

Following an application from ICP Ltd, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Malta, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to Padina pavonica-extract in Dictyolone® and an increase in bone mineral density. The Panel considers that the Padina pavonica-extract in Dictyolone® is sufficiently characterised. An increase (or reduced loss) in bone mineral density is a beneficial physiological effect. The applicant presented four human intervention studies, four animal studies and two in vitro studies as pertinent to the health claim. No conclusions could be drawn from two of the four human studies as they were carried out with a food that did not comply with the specifications of the food which is the subject of the health claim. The two other human studies did not show an effect of the Padina pavonica-extract in Dictyolone® on bone mineral density. The Panel concludes that a cause and effect relationship has not been established between the consumption of Padina pavonica-extract in Dictyolone® and an increase (or reduced loss) in bone mineral density.

Originalsprog	Engelsk

Forlag	Europen Food Safety Authority
DOI	https://doi.org/10.2903/j.efsa.2014.3518
Status	Udgivet - 2014
Udgivet eksternt	Ja

Emneord

Dictyolone
Padina pavonica
Bone mineral density
Health claims

Adgang til dokumentet

10.2903/j.efsa.2014.3518

Citationsformater

Publication, EFSA., & Tetens, I. (2014). EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2014. Scientific Opinion on the substantiation of a health claim related to Padina pavonica-extract in Dictyolone® and an increase in bone mineral density pursuant to Article 13(5) of Regulation (EC) No 1924/2006. Europen Food Safety Authority. https://doi.org/10.2903/j.efsa.2014.3518

EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2014. Scientific Opinion on the substantiation of a health claim related to Padina pavonica-extract in Dictyolone® and an increase in bone mineral density pursuant to Article 13(5) of Regulation (EC) No 1924/2006. / Publication, EFSA; Tetens, Inge.

Europen Food Safety Authority, 2014.

Publikation: Bog/antologi/afhandling/rapport › Rapport › Forskning › peer review

Publication, EFSA & Tetens, I 2014, EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2014. Scientific Opinion on the substantiation of a health claim related to Padina pavonica-extract in Dictyolone® and an increase in bone mineral density pursuant to Article 13(5) of Regulation (EC) No 1924/2006. Europen Food Safety Authority. https://doi.org/10.2903/j.efsa.2014.3518

Publication EFSA, Tetens I. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2014. Scientific Opinion on the substantiation of a health claim related to Padina pavonica-extract in Dictyolone® and an increase in bone mineral density pursuant to Article 13(5) of Regulation (EC) No 1924/2006. Europen Food Safety Authority, 2014. doi: 10.2903/j.efsa.2014.3518

@book{02cd33b1137e441b86bcd9a655ced830,

title = "EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2014. Scientific Opinion on the substantiation of a health claim related to Padina pavonica-extract in Dictyolone{\textregistered} and an increase in bone mineral density pursuant to Article 13(5) of Regulation (EC) No 1924/2006.",

abstract = "Following an application from ICP Ltd, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Malta, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to Padina pavonica-extract in Dictyolone{\textregistered} and an increase in bone mineral density. The Panel considers that the Padina pavonica-extract in Dictyolone{\textregistered} is sufficiently characterised. An increase (or reduced loss) in bone mineral density is a beneficial physiological effect. The applicant presented four human intervention studies, four animal studies and two in vitro studies as pertinent to the health claim. No conclusions could be drawn from two of the four human studies as they were carried out with a food that did not comply with the specifications of the food which is the subject of the health claim. The two other human studies did not show an effect of the Padina pavonica-extract in Dictyolone{\textregistered} on bone mineral density. The Panel concludes that a cause and effect relationship has not been established between the consumption of Padina pavonica-extract in Dictyolone{\textregistered} and an increase (or reduced loss) in bone mineral density.",

keywords = "Dictyolone, Padina pavonica, Bone mineral density, Health claims",

author = "EFSA Publication and Inge Tetens",

year = "2014",

doi = "10.2903/j.efsa.2014.3518",

language = "English",

publisher = "Europen Food Safety Authority",

}

TY - RPRT

T1 - EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2014. Scientific Opinion on the substantiation of a health claim related to Padina pavonica-extract in Dictyolone® and an increase in bone mineral density pursuant to Article 13(5) of Regulation (EC) No 1924/2006.

AU - Publication, EFSA

AU - Tetens, Inge

PY - 2014

Y1 - 2014

N2 - Following an application from ICP Ltd, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Malta, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to Padina pavonica-extract in Dictyolone® and an increase in bone mineral density. The Panel considers that the Padina pavonica-extract in Dictyolone® is sufficiently characterised. An increase (or reduced loss) in bone mineral density is a beneficial physiological effect. The applicant presented four human intervention studies, four animal studies and two in vitro studies as pertinent to the health claim. No conclusions could be drawn from two of the four human studies as they were carried out with a food that did not comply with the specifications of the food which is the subject of the health claim. The two other human studies did not show an effect of the Padina pavonica-extract in Dictyolone® on bone mineral density. The Panel concludes that a cause and effect relationship has not been established between the consumption of Padina pavonica-extract in Dictyolone® and an increase (or reduced loss) in bone mineral density.

AB - Following an application from ICP Ltd, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Malta, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to Padina pavonica-extract in Dictyolone® and an increase in bone mineral density. The Panel considers that the Padina pavonica-extract in Dictyolone® is sufficiently characterised. An increase (or reduced loss) in bone mineral density is a beneficial physiological effect. The applicant presented four human intervention studies, four animal studies and two in vitro studies as pertinent to the health claim. No conclusions could be drawn from two of the four human studies as they were carried out with a food that did not comply with the specifications of the food which is the subject of the health claim. The two other human studies did not show an effect of the Padina pavonica-extract in Dictyolone® on bone mineral density. The Panel concludes that a cause and effect relationship has not been established between the consumption of Padina pavonica-extract in Dictyolone® and an increase (or reduced loss) in bone mineral density.

KW - Dictyolone

KW - Padina pavonica

KW - Bone mineral density

KW - Health claims

U2 - 10.2903/j.efsa.2014.3518

DO - 10.2903/j.efsa.2014.3518

M3 - Report

BT - EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2014. Scientific Opinion on the substantiation of a health claim related to Padina pavonica-extract in Dictyolone® and an increase in bone mineral density pursuant to Article 13(5) of Regulation (EC) No 1924/2006.

PB - Europen Food Safety Authority

ER -